The US president's commitment via newly signed legislation comes after FBI director Christopher Wray revealed the agency thought the virus 'most likely' came from a Chinese laboratory leak in late 2019.
The US president's commitment via newly signed legislation comes after FBI director Christopher Wray revealed the agency thought the virus"most likely" came from a Chinese laboratory leak in late 2019.Joe Biden has vowed his administration will"declassify" as much information about the origins of COVID-19 as possible - including any potential links to a Chinese research lab.
Having ordered intelligence agencies including the FBI to investigate where the virus came from in 2021, the US president has now signed legislation that requires any details uncovered to be made public.'s origins to help ensure we can better prevent future pandemics," he said. Mr Biden's bill, which he said would only limit the sharing of any information that"would harm national security", comfortably passed through both the Senate and House of Representatives.thought the virus"most likely" came from a Chinese laboratory leakHe said Beijing - which has consistently rejected that assessment - was"doing its best to try to thwart and obfuscate" international efforts to learn more about the pandemic's origins.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Joe Biden signs law releasing all Covid origin records including Wuhan lab linksThe Biden administration will continue to review classified information 'including potential links to the Wuhan Institute of Virology', stated the president.
Read more »
Post COVID-19 irritable bowel syndromeObjectives The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut–brain interaction after hospitalisation for SARS-CoV-2 infection. Design GI-COVID-19 is a prospective, multicentre, controlled study. Patients with and without COVID-19 diagnosis were evaluated on hospital admission and after 1, 6 and 12 months post hospitalisation. Gastrointestinal symptoms, anxiety and depression were assessed using validated questionnaires. Results The study included 2183 hospitalised patients. The primary analysis included a total of 883 patients (614 patients with COVID-19 and 269 controls) due to the exclusion of patients with pre-existing gastrointestinal symptoms and/or surgery. At enrolment, gastrointestinal symptoms were more frequent among patients with COVID-19 than in the control group (59.3% vs 39.7%, p|0.001). At the 12-month follow-up, constipation and hard stools were significantly more prevalent in controls than in patients with COVID-19 (16% vs 9.6%, p=0.019 and 17.7% vs 10.9%, p=0.011, respectively). Compared with controls, patients with COVID-19 reported higher rates of irritable bowel syndrome (IBS) according to Rome IV criteria: 0.5% versus 3.2%, p=0.045. Factors significantly associated with IBS diagnosis included history of allergies, chronic intake of proton pump inhibitors and presence of dyspnoea. At the 6-month follow-up, the rate of patients with COVID-19 fulfilling the criteria for depression was higher than among controls. Conclusion Compared with controls, hospitalised patients with COVID-19 had fewer problems of constipation and hard stools at 12 months after acute infection. Patients with COVID-19 had significantly higher rates of IBS than controls. Trial registration number [NCT04691895][1]. Data are available upon reasonable request. Data are available on reasonable request. All figures have associated ra
Read more »
Lancashire neighbourhood's Covid worry as cases spike by 800%The latest coronavirus case figures show a worrying trend for one particular Lancashire area
Read more »
How a new app could help ten million Britons with long Covid, asthma and COPDThe app will be trialled in May and, if all goes smoothly, could be available by the end of the year, developers predict
Read more »
COVID did not affect happiness around the world, study revealsFor the second year in a row, acts of kindness that both led to and stemmed from greater happiness were also above pre-COVID pandemic levels.
Read more »